Uptake of the antileishmania drug tafenoquine follows a sterol-dependent diffusion process in Leishmania

J Antimicrob Chemother. 2011 Nov;66(11):2562-5. doi: 10.1093/jac/dkr345. Epub 2011 Aug 16.

Abstract

Objectives: The present study was designed to elucidate the mechanism of tafenoquine uptake in Leishmania and its sterol dependence.

Methods: Because tafenoquine is a fluorescent compound, spectrofluorimetric analysis allowed us to monitor its uptake by Leishmania promastigotes and intracellular amastigotes, and to evaluate the effect of temperature, energy and H+ gradient on drug entry. The influence of sterols on tafenoquine uptake in Leishmania parasites was determined in experiments using sterol-depleting agents such as methyl-β-cyclodextrin or cholesterol oxidase.

Results: Tafenoquine exhibited fast entry kinetics into Leishmania in an energy-independent, but pH- and temperature-dependent, non-saturable process. Furthermore, sterol depletion decreased tafenoquine uptake.

Conclusions: These findings suggest that Leishmania takes up tafenoquine by a diffusion process and that decreases in membrane sterol content may induce a decrease in drug uptake.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminoquinolines / metabolism*
  • Aminoquinolines / pharmacology
  • Antiprotozoal Agents / metabolism*
  • Antiprotozoal Agents / pharmacology
  • Biological Transport
  • Cell Membrane / metabolism
  • Cholesterol Oxidase / metabolism
  • Diffusion
  • Hydrogen-Ion Concentration
  • Leishmania major / drug effects
  • Leishmania major / growth & development
  • Leishmania major / metabolism*
  • Sterols / metabolism
  • Temperature
  • beta-Cyclodextrins / pharmacology

Substances

  • Aminoquinolines
  • Antiprotozoal Agents
  • Sterols
  • beta-Cyclodextrins
  • methyl-beta-cyclodextrin
  • tafenoquine
  • Cholesterol Oxidase